Compare Amylx Pharmaceuticals Inc (AMLX) vs Newmont Corporation (NEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Newmont Corporation — how do they compare? Amylx Pharmaceuticals Inc trades at $23.65 (market cap $2.64B), while Newmont Corporation trades at $118.97 (market cap $123.50B). The key difference: Newmont Corporation is far larger — about 46.8× Amylx Pharmaceuticals Inc's market cap, and Newmont Corporation pays a 0.89% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | NEM | |
|---|---|---|
Market Cap | $2.64B | $123.50B |
Sector | Health | Basic Materials |
52-Week High | $24.19 | $131.95 |
52-Week Low | $7.82 | $67.38 |
Enterprise Value | $2.39B | $120.09B |
Dividend Yield | — | 0.89% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Newmont Corporation
Newmont Corp is primarily a gold producer with operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, and Ghana. It is also engaged in the production of copper, silver, lead and zinc. The company's operations are organized in five geographic regions: North America, South America, Australia, Africa and Nevada.
Read more on NEM →
